Related Experiment Video
Updated: May 30, 2026
11:31
Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
Published on: September 18, 2013
Pathogenic LRRK2 mutations do not alter gene expression in cell model systems or human brain tissue.
Michael J Devine1, Alice Kaganovich, Mina Ryten
1Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom.
Plos One
|July 30, 2011
Summary
Point mutations in Leucine-Rich Repeat Kinase 2 (LRRK2) cause Parkinson's disease. This study found no significant changes in gene expression related to LRRK2 mutations, suggesting LRRK2 may not directly alter gene expression.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Point mutations in Leucine-Rich Repeat Kinase 2 (LRRK2) are a known cause of autosomal dominant Parkinson's disease (PD).
- The precise mechanisms underlying neurodegeneration in LRRK2-related PD remain incompletely understood.
- Investigating gene expression alterations is crucial for elucidating the molecular pathology of LRRK2 PD.
Purpose of the Study:
- To investigate global gene expression profiles in individuals and cell models with LRRK2 mutations.
- To determine if LRRK2 mutations are associated with significant alterations in basal gene expression.
- To explore the potential role of LRRK2 in the modulation of gene expression in Parkinson's disease.
Main Methods:
- Global gene expression analysis was performed using a case-control design.
- Three distinct systems were analyzed: fibroblasts from mutation carriers and controls, brain tissue from G2019S mutation carriers and controls, and inducible HEK293 cell lines with wild-type and mutant LRRK2.
- Statistical analysis included correction for multiple testing.
Main Results:
- No statistically significant alterations in global gene expression were detected across all three systems after correction for multiple testing.
- Any potential changes in basal gene expression associated with LRRK2 mutations in fibroblasts or cell lines appear to be quantitatively minor.
- The findings indicate a lack of substantial impact of LRRK2 mutations on overall gene expression levels under basal conditions.
Conclusions:
- LRRK2 mutations do not appear to directly modulate basal gene expression in the studied models.
- While LRRK2 may not play a direct role in regulating gene expression, its influence under specific pathogenic conditions cannot be entirely ruled out.
- Further research is warranted to understand the precise molecular mechanisms linking LRRK2 mutations to Parkinson's disease pathogenesis.
